Skip to main content
Middle East Current Psychiatry
Download PDF

Screening for depressive symptoms in patients with rheumatoid arthritis: relationship with pain severity, disease activity, and sleep quality

Middle East Current Psychiatry volume 29, Article number: 73 (2022) Cite this article

Abstract

Background

Rheumatoid arthritis (RA) is an autoimmune systemic condition that primarily affects all synovial joints, eventually leading to deformity and clinical disability. Much progress has been made in the evaluation of inflammation and disease activity in recent years; however, other factors that can influence these patients’ quality of life, including depression, stress, fatigue, sleep problems, fibromyalgia, sexual activity, and obesity, are often not evaluated by rheumatologists. Our purpose was to explore depressive symptoms in patients with RA and determine how they connected to other aspects of the disease, including pain severity, disease activity, and sleep quality.

Results

A cross-sectional study including 1200 patients with RA was performed. Paints with RA were classified into two groups based on the presence or absence of depressive symptoms using the Beck Depression Inventory-II (BDI-II). Group 1 included patients with both RA and depressive symptoms of varying severity; group 2 included patients with RA but without depressive symptoms. The patients underwent clinical evaluation and application of the Pittsburgh Sleep Quality Index (PSQI), Health Assessment Questionnaire for pain (HAQ-pain), and the Multidimensional Assessment of Fatigue scale (MAF). RA disease activity was evaluated using the DAS28 score. Depressive symptoms of varying severity were prevalent in 96% of our patients with RA, of whom 43.3% had minimal depression, while 13.7% had severe depression. The RA group with depression had a longer duration of disease, prolonged morning stiffness, and high disease activity measured by the DAS28 score than patients with only RA. In RA patients with concomitant depression, pain, sleep, and fatigue scores were also worse.

Conclusions

The presence of depression among patients with RA was associated with worse DAS28, HAQ, PASQI, and fatigue scores. Screening and recognition of such psychosocial disorders may help patients achieve optimal disease control and a good outcome.

Background

Rheumatoid arthritis (RA) is a chronic inflammatory condition that predominantly affects small and large joints. It can become deformable and debilitating if not properly diagnosed and treated [1]. With a prevalence of 0.4 to 1.3% and an incidence rate of 0.5 to 1%, RA is one of the 50 most common disorders causing global disability [2]. According to reports, 50–70% of patients with RA are seropositive [3]. Females outweigh males in terms of prevalence, with a ratio of 3:1 [4].

Depressive disorders affect approximately 38% of patients with RA [5]. Various mechanisms have been implicated in the pathophysiology of depression in RA. Socioeconomic factors such as low income, a lack of educational attainment, and unemployment are likely to act as possible factors in the development of depression in RA [6]. Patient factors such as age, race/ethnicity, and residence are all documented potential risk factors for depression, and they all have a direct impact on the alteration in depression scores in patients with RA [7].

It has been proposed that systemic chronic inflammatory conditions such as RA can cause, induce, or influence depressive symptoms [8]. As a result, depression in RA has been linked to activated inflammatory pathways and elevated proinflammatory cytokines like interleukin (IL-6) [9] and tumor necrosis factor (TNF-α) [10, 11]. Moreover, rather than being influenced by the acute clinical features of RA disease activity, depression in patients with RA may be a result of long-term functional limitations caused by arthritic joint damage [6].

Chronic inflammation that accompanies RA can inhibit the physiological coping mechanisms and stress reactions, which results in depression and a poor long-term prognosis for RA [12]. Furthermore, depression may also have an impact on RA patients, leading to lower medication adherence, difficulty sleeping, a higher risk of suicidal behavior, and a lower chance of reaching complete symptom remission [13].

The link between depression and sleep problems in patients with RA has been established [14]. Most sleep problems in patients with RA have been linked to a lower pain threshold, pain severity, depression, and activated inflammatory pathways [13]. This implies that sleep deprivation can lead to depression and that depression increases the likelihood of having sleep issues [15].

The necessity of proper recognition of these psychosocial disorders has received less research work in rheumatology, and they are frequently underdiagnosed, resulting in a delay in achieving good disease control [1]. The goal of this study was to screen for depression in patients with RA and explore its relationship to pain severity, disease activity, and sleep quality.

Methods

Patients with RA were recruited through the process of random cluster sampling from the inpatient and outpatient clinics of the Rheumatology and Rehabilitation Department of Al-Azhar University Hospitals. A total of 1200 patients were consecutively invited to participate in a single-center cross-sectional study over a period of 1 year starting in October 2017 and ending in October 2018, and the data analysis and explanation were done over another period of 6 months. To be included in the study, the patients had to be aged more than 18 years and fulfill the European League against Rheumatism/American College of Rheumatology (EULAR/ACR 2010) criteria for the diagnosis of RA [16]. According to the 2010 ACR/EULAR classification criteria for RA, the diagnosis of definite RA is determined by the presence of synovitis in at least one joint, the absence of a diagnosis that more adequately explains the synovitis, and the accomplishment of a total score of at least 6 (out of a possible 10) from the individual scores in four domains. For this calculation, the highest score obtained in a particular domain is considered.

Patients with other autoimmune rheumatic diseases, prior history, or current inflammatory joint disease other than RA (e.g., gout) were excluded from the study. The Disease Activity Score 28 (DAS28) was used for the assessment of RA disease activity [17].

The Arabic Version of Beck’s Depression Inventory—II (BDI-II) is a 21-item questionnaire used to screen and evaluate the severity of depressive symptoms. The range from 0 to 13 is considered minor, 14 to 19 is mild, 20 to 28 is moderate, and 29 to 63 is severe [18]. Ghareeb [19] produced the Arabic version, and psychometric features were evaluated across 17 Arabic-speaking nations.

Paints with RA were screened for depressive symptoms and classified into two groups. Group 1 included patients with both RA and depressive symptoms of varying severity; group 2 included patients with RA but without depressive symptoms.

The HAQ-pain scale is a 15-cm visual analog scale with anchor points of 0 (no pain) and 100 (very severe pain) [20].

The Arabic version of the multidimensional assessment of fatigue (MAF) covers the 4 dimensions of fatigue: severity, distress, interference in activities of daily living, and frequency and change during the previous week [21]. The MAF’s Arabic translation offers excellent validity and reliability [22].

The Pittsburgh Sleep Quality Index (PSQI) assesses self-reported sleep quality and disruptions during the previous month. Subjective sleep quality, sleep latency, sleep length, habitual sleep efficiency, sleep disruptions, use of sleeping medication, and daytime dysfunction are the seven components of sleep quality measured by the scale, which includes 19 items. The 7 component scores range from 0 to 21. The PSQI global score properly separates patients into “good sleepers” (PSQI total score ≤ 5) and “poor sleepers” (PSQI total score > 5) [23]. This questionnaire has been validated in Arabic [24].

According to 1990 ACR diagnostic criteria, fibromyalgia was determined by the presence of widespread pain (axial plus upper and lower segment plus left and right-sided pain), as well as mild to moderate tenderness at more than or equal to 11 of the 18 tender point sites on digital palpation [25].

This study was approved by the Research Ethics Committee of the Rheumatology and Rehabilitation Department at Al-Azhar University Hospitals, and all patients signed a written informed consent before entering the study. It is in accordance with the Helsinki Declaration’s legal principles. The privacy of all details of patients was granted, as each medical file containing all inquiries contained a code number.

Analysis

Data were coded and entered using the statistical package for the Social Sciences (SPSS) version 26 (IBM Corp., Armonk, NY, USA).

Results

Among 1200 patients with RA, 1152 (96%) were suffering from depressive symptoms. On assessing the severity of depression using the Beck Depression Inventory-II scale, we found that 520 (43.3%) of our patients had minimal depression, 236 (19.7%) had mild depression, 232 (19.3%) had moderate depression, and 164 (13.7%) had severe depression (as shown in Fig. 1).

Fig. 1
figure 1

Assessment of depression in the studied patients

Full size image

The demographic and clinical data of patients were summarized in Table 1.

Table 1 Demographic and clinical characteristics of RA patients with and without depression
Full size table

Both groups had no statistically significant differences concerning age or sex, whilst a small but significant difference in marital status was found. Patients with RA and depression had a longer disease duration, more erosive joint changes, more morning stiffness, and were more likely to have rheumatoid factors than RA patients without depression.

The DAS28 score showed a statistically significant difference between the groups. It was higher in the group with RA and depression than in the RA-only group (Table 2). This difference was related to the subjective components of the DAS28 (ESR, tender joints, and swollen joints), which were also statistically higher in the RA group than in the depression group. Additionally, high disease activity was more prevalent in the RA with depression group, together with a very small prevalence of low disease activity or remission. The mean HAQ-pain score was higher among patients with RA and concomitant depression (47.64 ± 26.01).

Table 2 The DAS28 (and related components) and HAQ in both RA groups
Full size table

There was significantly lower sleep quality in the RA with depression group as 67.4% of this group were poor sleepers. Higher rates of fatigue and fibromyalgia were also present in the RA with the depression group (Table 3).

Table 3 Symptoms related to depression in the 2 patient groups
Full size table

Regarding sleep quality assessment in our patients, all components of the PASQI score showed a highly statistically significant difference between groups (Table 4). The group of RA with depression showed higher scores (indicating worse sleep quality) in all components as well as the total PASQI score.

Table 4 Global PSQI and its component scores in the 2 groups
Full size table

Discussion

Depression, a common disorder among patients with RA, has been shown to be frequently underestimated [26] and is considered a major cause of mortality [27]. A higher rate of depression is noticed among Egyptian patients with RA, and clinicians must keep an eye on this often-overlooked comorbidity [28]. In our sample, depressive symptoms were observed in 1152 (96%) of patients affected by RA, which emerged to be significantly greater than the earlier published prevalence. Although severe depression was noticed in 13.7% of patients, the majority (43.3%) had minimal depression, which came in line with Sruamsiri et al. [29].

Depression has been shown to afflict 9.5 to 41.5% of patients with RA [30], which is up to three times the general population [31] and is by far the most prevalent condition in RA [32]. Three Egyptian studies found varying rates of depression among patients with RA, with two of them reporting depression rates of 15.3% and 23%, respectively [33, 34], and the third, done by Elsherbiny et al. [35], revealing a prevalence of 45%, which was close to the percentage reported in several cohorts [7, 36]. These differences in frequency between studies, particularly among Egyptian patients with RA, could be attributed to differences in research methodology, sample size, depression detection methods, and/or the type of medical institutions involved in each study.

Low economic income, unemployment, low educational level, RA disability, and other comorbidities, on the other hand, may explain the high prevalence of depression among our patients with RA.

According to Karpouzas et al. [37], longer disease duration, more erosive joint changes, longer morning stiffness, and rheumatoid factor positivity were all associated with depression in patients with RA.

In individuals with RA, the Larsen score, which evaluates erosive joint damage, has been linked to depression. This is most likely because the significant erosive joint changes associated with RA can lead to decreased physical ability and impaired function, which can affect a person’s psychological health and, as a result, the likelihood of depression.

DAS28 and related variables were found to be significantly related to depression in patients with RA; this was confirmed by Kwiatkowska et al. [38]. Furthermore, Li et al. [39] discovered a link between depression and disease activity, demonstrating that higher levels of inflammatory cytokines implicated in disease activity such as interleukin-6 (IL-6) may have an impact on depression, implying that pro-inflammatory cytokines may play a role in the development of this condition.

Patients with RA and concurrent depression had significantly higher HAQ-pain and lower QoL scores, confirming the findings of a prior study [40].

This study showed that depression among patients with RA was associated with poor sleep quality, worsening fatigue scores, and an increased rate of FM. We found that 38.3% of our patients with RA and depression also had FM. Depression is one of the most frequent comorbidities in the FM population, with an average lifetime incidence of approximately 63% [41]. Furthermore, depressive disorders are three times more common in FM patients than in the general population [42] and FM patients show a higher incidence of depression than people with other chronic pain disorders [43]. In RA, pro-inflammatory cytokines including TNF and IL-6 have been implicated in central sensitization and the development of FM [44].

Sleep deprivation or discontinuity has been shown to influence sleep quality in patients with RA, and poor sleep quality has been linked to depression, high disease activity, a high pain threshold, and fatigue [45]. According to the current study’s findings, 67.4% of patients with RA and concurrent depression were shown to have poor sleep quality and worsening of all sleep components as measured by the PASQI. Past research by Rezaei et al. [46] confirmed our findings, stating that sleep difficulties may be more common in RA patients due to disease activity, pain chronicity, fatigue, and depression.

According to Irwin et al. [45], the pathophysiology of sleep problems may be explained by increased nuclear factor kappa-B (NF-kB) signaling, resulting in persistent hyperalgesia; thus, the link between sleep problems and pain is reciprocal.

Despite the fact that a few previous studies in Egyptian patients with RA investigated the prevalence of depression and its association with disease activity [33, 34, 47,48,49], neither of these patients with RA had been assessed or treated for depression, nor had their symptoms been addressed during follow-up evaluations. This exemplifies how depression is frequently overlooked in patients with RA.

The study’s main limitation was the lack of a non-RA healthy control group with which to compare results. Because we intend to screen for and correlate depressive symptoms in patients with RA, we anticipated that the proposed study design would provide potentially useful information regarding this patient population. Future research may address the research issue more effectively by employing a different or more robust methodology.

Conclusions

Depression is a common psychiatric disorder among patients with RA and needs to be assessed as part of the disease management process. Depression was associated with worsened HAQ-pain, PASQI, and fatigue ratings, as well as an increase in DAS28. Screening for depression in patients with RA should be done on a regular basis in order to help patients achieve significant improvement or remission.

Availability of data and materials

The data will be available upon reasonable request.

Abbreviations

PASQI:

Pittsburgh Sleep Quality Index

HAQ:

Health Assessment Questioner

DAS28:

Disease activity score in 28 joints

ESR:

Erythrocyte sedimentation rate

IL-6:

Interleukin-6

References

  1. Albayrak Gezer İ, Balkarli A, Can B, Bağçaci S, Küçükşen S, Küçük A (2017) Pain, depression levels, fatigue, sleep quality, and quality of life in elderly patients with rheumatoid arthritis. Turkish J Med Sci 47(3):847–853. https://doi.org/10.3906/sag-1603-147

    Article  Google Scholar 

  2. Littlejohn EA, Monrad SU, Diagnosis E (2018) Treatment of rheumatoid arthritis. Prim Care Clin Off Pract 45(2):237–255. https://doi.org/10.1016/j.pop.2018.02.010

    Article  Google Scholar 

  3. Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8

    Article  CAS  PubMed  Google Scholar 

  4. Beşirli A, Jö A, Kaymak D, Özer ÖA (2020) The relationship between anxiety, depression, suicidal ideation and quality of life in patients with rheumatoid arthritis. Psychiatr Q 91(1):53–64. https://doi.org/10.1007/s11126-019-09680-x

    Article  PubMed  Google Scholar 

  5. Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52(12):2136–2148. https://doi.org/10.1093/rheumatology/ket169

    Article  Google Scholar 

  6. Margaretten M, Julian L, Katz P, Yelin E (2011) Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol 6(6):617–623. https://doi.org/10.2217/IJR.11.6

    Article  Google Scholar 

  7. Margaretten M, Yelin E, Imboden J, Graf J, Barton J, Katz P, Julian L (2009) Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum 61(11):1586–1591. https://doi.org/10.1002/art.24822

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65(9):732–741. https://doi.org/10.1016/j.biopsych.2008.11.029

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HK, Kling MA, Chrousos GP, Gold PW (2005) Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 90(5):2522–2530. https://doi.org/10.1210/jc.2004-1667

    Article  CAS  PubMed  Google Scholar 

  10. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 170(4):429–433. https://doi.org/10.1007/s00213-003-1566-z

    Article  CAS  PubMed  Google Scholar 

  11. Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2):171–186. https://doi.org/10.1097/PSY.0b013e3181907c1b

    Article  CAS  PubMed  Google Scholar 

  12. Lwin MN, Serhal L, Holroyd C, Edwards CJ (2020) Rheumatoid arthritis: the impact of mental health on disease: a narrative review. Rheumatol Ther 7(3):457–471. https://doi.org/10.1007/s40744-020-00217-4

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lee Y, Chibnik L, Lu B, Wasan A, Edwards R, Fossel A et al (2009) The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 11:R160

    Article  Google Scholar 

  14. Franzen L, Buysse DJ (2008) Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci 10(4):473–481

    Article  Google Scholar 

  15. Fiest KM, Hitchon CA, Bernstein CN et al (2017) Systematic review and meta-analysis of interventions for depression and anxiety in persons with rheumatoid arthritis. J Clin Rheumatol 23:425–443. https://doi.org/10.1097/RHU.0000000000000489

    Article  PubMed  PubMed Central  Google Scholar 

  16. Aletaha D, Neogi T, Silman A et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581

    Article  Google Scholar 

  17. Prevoo M, Van’t Hof M, Kuper H, Van Leeuwen M, Van de Putte L, Van Riel P (1995) Modified disease activity scores that include twenty – eight –joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48

    Article  CAS  Google Scholar 

  18. Beck A, Steer R, Brown G (1988) Manual for the Beck depression inventory, 2nd edn. Psychological Corporation, San Antonio

    Google Scholar 

  19. Ghareeb AG (2000) Manual of the Arabic BDI-II. Alongo Press. Cairo inventory: the author’s twenty-five years of evaluation. Clin Psychol Rev 8:77–100

    Google Scholar 

  20. Fries J, Spitz P, Young D (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9:789–793

    CAS  PubMed  Google Scholar 

  21. Tack B (1991) Dimensions and correlates of fatigue in older adults with rheumatoid arthritis [PhD dissertation]. University Of California, San Francisco, San Francisco

    Google Scholar 

  22. Bahouq H, Rostom S, Bahiri R, Hakkou J, Aissaoui N, Hajjaj-Hassouni N (2012) Psychometric evaluation of the Arabic version of the multidimensional assessment of fatigue scale (MAF) for use in patients with ankylosing spondylitis. Rheumatol Int 32(12):3969–3976. https://doi.org/10.1007/s00296-011-2306-z

    Article  PubMed  Google Scholar 

  23. Buysse D, Reynolds C, Monk T, Berman S, Kupfer D (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213

    Article  CAS  Google Scholar 

  24. Suleiman KH, Yates BC, Berger AM, Pozehl B, Meza J (2010) Translating the Pittsburgh sleep quality index into Arabic. West J Nurs Res 32(2):250–268

    Article  Google Scholar 

  25. Wolfe F, Smythe H, Yunus M, Bennett R, Bombardier C, Goldenberg D, Tugwell P, Campbell S, Abeles M, Clark P (1990) The American College of Rheumatology 1990criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172

    Article  CAS  Google Scholar 

  26. Nagyova I, Stewart RE, Macejova Z, van Dijk JP, van den Heuvel WJ (2005) The impact of pain on psychological well-being in rheumatoid arthritis: the mediating effects of self-esteem and adjustment to disease. Patient Educ Couns 58(1):55–62

    Article  Google Scholar 

  27. Ang D, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013–1019

    PubMed  Google Scholar 

  28. Hammam N, Gamal RM, Rashed AM, Elfetoh NA, Mosad E, Khedr EM (2020) Fatigue in rheumatoid arthritis patients: association with sleep quality, mood status, and disease activity. Reumatol Clin 16(5):339–344

    Article  Google Scholar 

  29. Sruamsiri R, Mahlich J, Tanaka E, Yamanaka H (2018) Productivity loss of Japanese patients with rheumatoid arthritis – a cross-sectional survey. Mod Rheumatol 28(3):482–489

    Article  Google Scholar 

  30. Zhang L, Cai P, Zhu W (2020) Depression has an impact on disease activity and health-related quality of life in rheumatoid arthritis: a systematic review and meta-analysis. Int J Rheum Dis 23(3):285–293

    Article  Google Scholar 

  31. Kim SY, Chanyang M, Oh DJ, Choi HG (2020) Association between depression and rheumatoid arthritis: two longitudinal follow-up studies using a national sample cohort. Rheumatology 59(8):1889–1897

    Article  CAS  Google Scholar 

  32. Intriago M, Maldonado G, Cardenas J, Rios C (2019) Quality of life in Ecuadorian patients with established rheumatoid arthritis. Open Access Rheumatol Res Rev 11:199–205

    Google Scholar 

  33. Mostafa H, Radwan A (2013) The relationship between disease activity and depression in Egyptian patients with rheumatoid arthritis. Egypt Rheumatol 35(4):193–199

    Article  Google Scholar 

  34. Abdel-Nasser AM, Abd El-Azim S, Taal E, El-Badawy SA, Rasker JJ, Valkenburg HA (1998) Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants. Br J Rheumatol 37(4):391–397

    Article  CAS  Google Scholar 

  35. Elsherbiny D, Saad W (2020) Depression in rheumatoid arthritis patients: screening for a frequent yet underestimated comorbidity. Egypt Rheumatol 42:89–93

    Article  Google Scholar 

  36. Maldonado G, Ríos C, Paredes C, Ferro C, Intriago MJ, Aguirre C et al (2017) Depression in rheumatoid arthritis. Rev Colomb Reumatol 24(2):84–91

    Google Scholar 

  37. Karpouzas GA, Dolatabadi S, Moran R, Li N, Nicassio PM (2012) Weisman Correlates and predictors of disability in vulnerable US Hispanics with rheumatoid arthritis. Arthritis Care Res 64(9):1274–1281

    Article  Google Scholar 

  38. Kwiatkowska B, Kłak A, Maślińska M, Mańczak M, Raciborski F (2018) Factors of depression among patients with rheumatoid arthritis. Reumatologia 56(4):219–227

    Article  Google Scholar 

  39. Li Y-C, Chou Y-C, Chen H-C, Lu C-C, Chang D-M (2019) Interleukin-6 and interleukin-17 are related to depression in patients with rheumatoid arthritis. Int J Rheum Dis 22(6):980–985. https://doi.org/10.1111/1756-185X.13529

    Article  CAS  PubMed  Google Scholar 

  40. Anyfanti P, Gavriilaki E, Pyrpasopoulou A, Triantafyllou G, Triantafyllou A, Chatzimichailidou S et al (2016) Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated. Clin Rheumatol 35(3):733–739

    Article  Google Scholar 

  41. Kleykamp BA, Ferguson MC, McNicol E et al (2021) The prevalence of psychiatric and chronic pain comorbidities in fibromyalgia: an ACTTION systematic review. Semin Arthritis Rheum 51(1):166–174

    Article  Google Scholar 

  42. Løge-Hagen JS, Sæle A, Juhl C et al (2019) Prevalence of depressive disorder among patients with fibromyalgia: systematic review and meta-analysis. J Affect Disord 245:1098–1105

    Article  Google Scholar 

  43. Gracely RH, Ceko M, Bushnell MC (2012) Fibromyalgia and depression. Pain Res Treat 2012:486590

    PubMed  Google Scholar 

  44. Shresher NM, Mohamed AE, Elshahaly MH (2019) Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis. Rheumatol Int 39(10):1703–1710. https://doi.org/10.1007/s00296-019-04403-8

    Article  CAS  PubMed  Google Scholar 

  45. Irwin MR, Olmstead R, Carrillo C et al (2012) Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 35(4):537–543. https://doi.org/10.5665/sleep.1742

    Article  PubMed  PubMed Central  Google Scholar 

  46. Rezaei M, Khormali M, Akbarpour S, Sadeghniiat-Hagighi K, Shamsipour M (2018) Sleep quality and its association with psychological distress and sleep hygiene: a cross-sectional study among pre-clinical medical students. Sleep Sci 11(4):274–280

    Article  Google Scholar 

  47. Hassan AA, Nasr MH, Mohamed AL, Kamal AM, Elmoghazy AD (2019) Psychological affection in rheumatoid arthritis patients in relation to disease activity. Medicine (Baltimore) 98(19):e15373

    Article  Google Scholar 

  48. Abu Al-Fadl EM, Ismail MA, Thabit M, El-Serogy Y (2014) Assessment of health-related quality of life, anxiety and depression in patients with early rheumatoid arthritis. Egypt Rheumatol 36(2):51–56

    Article  Google Scholar 

  49. El-Najjar AR, Negm MG, El-Sayed WM (2014) The relationship between depression, disease activity and physical function in juvenile idiopathic arthritis patients in Zagazig University Hospitals – Egypt. Egypt Rheumatol 36(3):145–150

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Author information

Authors and Affiliations

  1. Department of Rheumatology and Rehabilitation, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

    Adel Ibrahim Azzam

  2. Department of Psychiatry, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

    Mohamed Lamlom & Ahmed Mohamed Khalifa

Authors
  1. Adel Ibrahim Azzam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed Lamlom
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed Mohamed Khalifa
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

A.I.A. conceived and designed the analysis and supervision of the work, and A.M.K contributed to the manuscript writing. M.L. contributed to the data collection and aided in the result interpretation. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Adel Ibrahim Azzam.

Ethics declarations

Ethics approval and consent to participate

The Rheumatology Department ethical committee, Faculty of Medicine, Al-Azhar University, approved this study. It adheres to the legal principles outlined in the Helsinki declaration. Each participant provided written informed consent. Because each medical file containing all inquiries contained a code number, all patient details were kept private.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Azzam, A.I., Lamlom, M. & Khalifa, A.M. Screening for depressive symptoms in patients with rheumatoid arthritis: relationship with pain severity, disease activity, and sleep quality. Middle East Curr Psychiatry 29, 73 (2022). https://doi.org/10.1186/s43045-022-00239-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43045-022-00239-4

Keywords

  • Depression
  • RA
  • DAS28
  • PASQI